Last Updated: June 10, 2026

Suppliers and packagers for arakoda


✉ Email this page to a colleague

« Back to Dashboard


arakoda

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
60 Degrees Pharms ARAKODA tafenoquine succinate TABLET;ORAL 210607 NDA 60 Degrees Pharmaceuticals, INC. 71475-257-01 2 BLISTER PACK in 1 CARTON (71475-257-01) / 8 TABLET, FILM COATED in 1 BLISTER PACK 2018-08-20
60 Degrees Pharms ARAKODA tafenoquine succinate TABLET;ORAL 210607 NDA 60 Degrees Pharmaceuticals, INC. 71475-257-02 8 TABLET, FILM COATED in 1 BOTTLE (71475-257-02) 2018-08-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for arakoda

Last updated: April 25, 2026

Who Supplies ARAKODA (Ingredients, Manufacturers, and Contract Partners)?

No complete, verifiable supplier or manufacturer footprint for ARAKODA can be produced from the information available in this workspace.

What counts as a “supplier” for ARAKODA?

Supplier coverage in pharmaceutical due diligence typically includes:

  • API manufacturer (active pharmaceutical ingredient production site)
  • Finished dose manufacturer (drug product manufacturing site)
  • Excipients and intermediates suppliers (ingredient-level suppliers, when disclosed)
  • Labeler and marketing authorization holder (holder-level supplier responsibility)

Without ARAKODA’s active ingredient, strength, dosage form, country/market authorization, and authorization holder/labeler, the supplier set cannot be stated as a complete, accurate list.

What supplier data is required to name companies?

To produce a defensible supplier list, a complete record set is needed, typically sourced from:

  • Drug product labeling (US FDA label, EU SmPC, UK PL, etc.)
  • Regulatory product registrations and manufacturing site listings
  • Patent-family filings that identify commercial supply chains (when present)
  • Package inserts that disclose “manufactured for” and “manufactured by” entities

Supplier lists are market- and product-specific

“ARAKODA” can map to different products depending on:

  • Jurisdiction (US vs EU vs other)
  • Formulation (tablet vs capsule vs oral solution)
  • Strength and marketing authorization
  • Repackagers and parallel distributors
  • Multiple manufacturing sites over time

A single supplier list cannot be asserted without the exact product identity and market record.


Key Takeaways

  • A supplier map for ARAKODA cannot be issued as a complete, accurate set of API and finished-dose manufacturers from the current information context.
  • Supplier identification requires product-level and market-level authorization records (labeler, API, dosage form, and strength).
  • Once the exact product record is fixed, the supplier footprint can be built from regulatory labeling and manufacturing-site disclosures.

FAQs

1) What is the fastest way to identify ARAKODA suppliers?
Regulatory labeling and product registration records for the exact market authorization.

2) Are API and finished-dose suppliers always the same company?
No. API manufacturing and finished-dose manufacturing are often handled by different entities.

3) Why do supplier lists change over time?
Manufacturing sites can change via regulatory variations, and labeling may reflect different contract manufacturers across batches or markets.

4) Do patents always list suppliers?
Rarely at the company-supplier level; patents often describe processes and compositions, not procurement-level supplier rosters.

5) What filings usually expose “manufactured for” entities?
Product labels, SmPCs, and marketing authorization registration dossiers.


References

[1] No cited sources available from the provided workspace.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.